HTL Biotechnology
Clément Georgoux is a Product Manager at HTL Biotechnology since October 2023 and has been actively involved with SoluSanté: Pharmacie & Biotechnologies as President and Co-Founder while also serving as a member of the Strategic Orientation Committee since June 2020. Previous experience includes roles at Viatris as Assistant Chef de Produit Biosimilaires, focusing on oncology and immunology products, and two externships at CHU Grenoble Alpes, where responsibilities included the implementation of medical device delivery processes. Clément also held marketing and clinical trial positions at Techni-Pharma, Eurofins Optimed Clinical Research, and worked in various pharmacy settings. Clément is pursuing a Master 2 in Marketing Pharmaceutique at Université Paris-Saclay and has completed multiple MOOCs related to management and health.
This person is not in any offices
HTL Biotechnology
HTL is the world leader in the development and production of pharmaceutical grade biopolymers used to develop life-changing treatments for millions of patients. A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined for over 30 years its innovative functional biopolymer platform that has enabled it to produce "customised" pharmaceutical grade products for the leaders of the pharmaceutical and medical devices sectors in therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology and urology Thanks to its dedicated R&D team, its partnerships and its incubator, HTL is now driving innovation in the biopolymer sector. Its R&D strategy aims to address unmet medical needs by creating new types of biopolymers, modifying their physico-chemical properties, and exploring new medical applications in cutting-edge areas such as bioprinting and drug delivery. very.